The ets transcription factor Fli-1 in development, cancer and disease.

作者: Y Li , H Luo , T Liu , E Zacksenhaus , Y Ben-David

DOI: 10.1038/ONC.2014.162

关键词:

摘要: Friend leukemia virus-induced erythroleukemia-1 (Fli-1), an E26 transformation specific (ETS) transcription factor, was isolated a quarter century ago through retrovirus mutagenesis screen. Fli-1 has since been recognized to play critical roles in normal development and homeostasis. For example, it transcriptionally regulates genes that drive hematopoiesis vasculogenesis. Indeed, is one of 10 key regulators hematopoietic stem/progenitor cell maintenance differentiation. Aberrant expression also underlies number virally induced leukemias, including erythroleukemia various types human cancers, the target chromosomal translocations childhood Ewing's sarcoma. Abnormal important etiology autoimmune diseases such as systemic lupus erythematosus sclerosis. These studies establish strong candidate for drug development. Despite difficulties targeting factors, recent identified small-molecule inhibitors Fli-1. Here we review past ongoing research on with emphasis its mechanistic function disease malignant transformation. The significance identifying their clinical applications treatment cancer deregulated are discussed.

参考文章(120)
George K Bertsias, Nektaria Goulidaki, Christianna Choulaki, Dimitrios T Boumpas, Magdalene Nakou, Eva D Papadimitraki, Prodromos Sidiropoulos, Antonios Fanouriakis, Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells. Clinical and Experimental Rheumatology. ,vol. 31, pp. 172- 179 ,(2013)
Della Rossa A, Stagnaro C, Barsotti S, Systemic sclerosis: a critical digest of the recent literature. Clinical and Experimental Rheumatology. ,vol. 33, pp. 172- ,(2015)
Yoshihide Asano, Lukasz Stawski, Faye Hant, Kristin Highland, Richard Silver, Gabor Szalai, Dennis K. Watson, Maria Trojanowska, Endothelial Fli1 Deficiency Impairs Vascular Homeostasis The American Journal of Pathology. ,vol. 176, pp. 1983- 1998 ,(2010) , 10.2353/AJPATH.2010.090593
Dave Cervi, Christina R. Lee, Amandine H L Truong, Aloke Sarkar, You Jun Li, Yaacov Ben-David, Friend virus-induced erythroleukemias: A unique and well-defined mouse model for the development of leukemia Anticancer Research. ,vol. 23, pp. 2159- 2166 ,(2003)
M.J. Klemsz, R.A. Maki, T. Papayannopoulou, J. Moore, R. Hromas, Characterization of the ets oncogene family member, fli-1. Journal of Biological Chemistry. ,vol. 268, pp. 5769- 5773 ,(1993) , 10.1016/S0021-9258(18)53385-8
Patrick J. Grohar, Laurie B. Griffin, Choh Yeung, Qing-Rong Chen, Yves Pommier, Chand Khanna, Javed Khan, Lee J. Helman, Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells. Neoplasia. ,vol. 13, pp. 145- 153 ,(2011) , 10.1593/NEO.101202
J. Mathenia, E. Reyes-Cortes, S. Williams, I. Molano, P. Ruiz, D. K. Watson, G. S. Gilkeson, X. K. Zhang, Impact of Fli-1 transcription factor on autoantibody and lupus nephritis in NZM2410 mice Clinical and Experimental Immunology. ,vol. 162, pp. 362- 371 ,(2010) , 10.1111/J.1365-2249.2010.04245.X
S. Noda, Y. Asano, K. Akamata, N. Aozasa, T. Taniguchi, T. Takahashi, Y. Ichimura, T. Toyama, H. Sumida, K. Yanaba, Y. Tada, M. Sugaya, T. Kadono, S. Sato, Constitutive activation of c‐Abl/protein kinase C‐δ/Fli1 pathway in dermal fibroblasts derived from patients with localized scleroderma British Journal of Dermatology. ,vol. 167, pp. 1098- 1105 ,(2012) , 10.1111/J.1365-2133.2012.11055.X
Sarah Bradshaw, W. Jim Zheng, Lam C. Tsoi, Gary Gilkeson, Xian K. Zhang, A role for Fli-1 in B cell proliferation: Implications for SLE pathogenesis Clinical Immunology. ,vol. 129, pp. 19- 30 ,(2008) , 10.1016/J.CLIM.2008.05.010